MX363478B - 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas. - Google Patents
3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.Info
- Publication number
- MX363478B MX363478B MX2014001599A MX2014001599A MX363478B MX 363478 B MX363478 B MX 363478B MX 2014001599 A MX2014001599 A MX 2014001599A MX 2014001599 A MX2014001599 A MX 2014001599A MX 363478 B MX363478 B MX 363478B
- Authority
- MX
- Mexico
- Prior art keywords
- ridinones
- naphthy
- dihydro
- antibacterial
- piperidinyl substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere a compuestos de fórmula (I) novedosos que inhiben la actividad de la enzima Fabl, los cuales son por lo tanto útiles en el tratamiento de infecciones bacterianas; también se refiere a composiciones farmacéuticas que comprenden estos compuestos y a procesos químicos para la preparación de estos compuestos.(ver Fórmula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11177116 | 2011-08-10 | ||
PCT/EP2012/065730 WO2013021052A1 (en) | 2011-08-10 | 2012-08-10 | Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014001599A MX2014001599A (es) | 2014-04-25 |
MX363478B true MX363478B (es) | 2019-03-22 |
Family
ID=46724388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014001599A MX363478B (es) | 2011-08-10 | 2012-08-10 | 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas. |
Country Status (13)
Country | Link |
---|---|
US (2) | US9012634B2 (es) |
EP (1) | EP2742047B1 (es) |
JP (2) | JP6294822B2 (es) |
KR (1) | KR101967174B1 (es) |
CN (2) | CN103917540B (es) |
AU (1) | AU2012293619B2 (es) |
BR (1) | BR112014002958B1 (es) |
CA (1) | CA2842531C (es) |
EA (1) | EA201490435A1 (es) |
ES (1) | ES2881681T3 (es) |
HK (2) | HK1199727A1 (es) |
MX (1) | MX363478B (es) |
WO (1) | WO2013021052A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9012634B2 (en) * | 2011-08-10 | 2015-04-21 | Janssen R&D Ireland | Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones |
JO3611B1 (ar) | 2011-08-10 | 2020-08-27 | Janssen Sciences Ireland Uc | سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم |
EP2785715A1 (en) * | 2011-12-02 | 2014-10-08 | Aurigene Discovery Technologies Limited | Substituted pyridine derivatives as fabi inhibitors |
US9062075B2 (en) | 2011-12-02 | 2015-06-23 | Aurigene Discovery Technologies Limited | Tetrahydropyridine derivatives as FabI inhibitors |
WO2014072930A2 (en) * | 2012-11-09 | 2014-05-15 | Aurigene Discovery Technologies Limited | Fused pyridine derivatives as antibacterial agents |
EP3004099B1 (en) * | 2013-06-04 | 2023-04-19 | Aurigene Oncology Limited | Tetrahydropyridine derivatives as fabi inhibitors |
WO2015071780A1 (en) * | 2013-11-12 | 2015-05-21 | Aurigene Discovery Technologies Limited | Alkylidine substituted heterocyclyl derivatives as anti-bacterial agents |
LT6177B (lt) | 2014-10-10 | 2015-07-27 | Uab "Biocentras" | Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas |
CN107652226B (zh) * | 2017-11-15 | 2020-03-31 | 上海皓伯化工科技有限公司 | 一种N-Boc-4-哌啶甲醛的制备方法 |
KR102037494B1 (ko) | 2017-12-11 | 2019-10-28 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
KR20190120112A (ko) | 2019-10-08 | 2019-10-23 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
CN113527220A (zh) * | 2021-07-26 | 2021-10-22 | 京博农化科技有限公司 | 一种脱硫丙硫菌唑异构体的合成方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215123A (en) | 1979-05-07 | 1980-07-29 | American Home Products Corporation | Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
ES2270874T3 (es) | 1999-10-08 | 2007-04-16 | Affinium Pharmaceuticals, Inc. | Inhibidores de fab i. |
IL148820A0 (en) | 1999-10-08 | 2002-09-12 | Smithkline Beecham Corp | Fab i inhibitors |
AU1192501A (en) | 1999-10-08 | 2001-04-23 | Smithkline Beecham Corporation | Fab i inhibitors |
WO2003088897A2 (en) | 2001-04-06 | 2003-10-30 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
JP5087406B2 (ja) | 2004-06-04 | 2012-12-05 | アフィニウム ファーマシューティカルズ, インク. | 治療薬ならびにその製造方法および使用方法 |
US7732612B2 (en) | 2004-09-09 | 2010-06-08 | Janssen Pharmaceutica, N.V. | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
US7973060B2 (en) | 2005-10-13 | 2011-07-05 | Crystalgenomics, Inc. | Fab I inhibitor and process for preparing same |
WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
WO2008098374A1 (en) | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
AU2010320963B2 (en) | 2009-11-18 | 2015-07-09 | Fab Pharma Sas | Novel heterocyclic acrylamides and their use as pharmaceuticals |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
US9012634B2 (en) * | 2011-08-10 | 2015-04-21 | Janssen R&D Ireland | Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones |
JO3611B1 (ar) | 2011-08-10 | 2020-08-27 | Janssen Sciences Ireland Uc | سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم |
-
2012
- 2012-08-10 US US14/237,851 patent/US9012634B2/en active Active
- 2012-08-10 MX MX2014001599A patent/MX363478B/es unknown
- 2012-08-10 AU AU2012293619A patent/AU2012293619B2/en not_active Ceased
- 2012-08-10 CN CN201280039121.6A patent/CN103917540B/zh active Active
- 2012-08-10 EA EA201490435A patent/EA201490435A1/ru unknown
- 2012-08-10 BR BR112014002958-0A patent/BR112014002958B1/pt not_active IP Right Cessation
- 2012-08-10 JP JP2014524409A patent/JP6294822B2/ja active Active
- 2012-08-10 CA CA2842531A patent/CA2842531C/en active Active
- 2012-08-10 WO PCT/EP2012/065730 patent/WO2013021052A1/en active Application Filing
- 2012-08-10 ES ES12750575T patent/ES2881681T3/es active Active
- 2012-08-10 EP EP12750575.8A patent/EP2742047B1/en active Active
- 2012-08-10 CN CN201610095183.9A patent/CN105503869A/zh active Pending
- 2012-08-10 KR KR1020147004176A patent/KR101967174B1/ko active IP Right Grant
-
2015
- 2015-01-07 HK HK15100116.2A patent/HK1199727A1/zh not_active IP Right Cessation
- 2015-02-17 US US14/624,452 patent/US9598407B2/en active Active
-
2016
- 2016-10-17 HK HK16111928.6A patent/HK1223614A1/zh unknown
-
2017
- 2017-06-07 JP JP2017112306A patent/JP6552550B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CN105503869A (zh) | 2016-04-20 |
CA2842531A1 (en) | 2013-02-14 |
MX2014001599A (es) | 2014-04-25 |
KR20140079759A (ko) | 2014-06-27 |
JP2014521715A (ja) | 2014-08-28 |
EA201490435A1 (ru) | 2014-06-30 |
WO2013021052A1 (en) | 2013-02-14 |
US9012634B2 (en) | 2015-04-21 |
HK1199727A1 (zh) | 2015-07-17 |
JP6552550B2 (ja) | 2019-07-31 |
AU2012293619B2 (en) | 2017-05-04 |
CN103917540B (zh) | 2016-03-16 |
CN103917540A (zh) | 2014-07-09 |
US9598407B2 (en) | 2017-03-21 |
EP2742047A1 (en) | 2014-06-18 |
CA2842531C (en) | 2019-07-16 |
EP2742047B1 (en) | 2021-05-12 |
BR112014002958A2 (pt) | 2017-02-21 |
US20150158866A1 (en) | 2015-06-11 |
BR112014002958B1 (pt) | 2020-10-06 |
ES2881681T3 (es) | 2021-11-30 |
AU2012293619A1 (en) | 2014-02-06 |
HK1223614A1 (zh) | 2017-08-04 |
JP6294822B2 (ja) | 2018-03-14 |
KR101967174B1 (ko) | 2019-04-09 |
US20140163038A1 (en) | 2014-06-12 |
JP2017222647A (ja) | 2017-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX363478B (es) | 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas. | |
NZ708928A (en) | Mannose derivatives for treating bacterial infections | |
JO3611B1 (ar) | سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم | |
MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
MX349827B (es) | Compuestos que contienen nitrogeno y su uso. | |
MX2014001598A (es) | 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con homopiperidinilo antibacterianas. | |
MX2013002660A (es) | Heteroarilmetilamidas. | |
MX2011008043A (es) | Derivados de actagardina. | |
MX2013004759A (es) | Compuestos de oxima como agentes de elevacion de colesterol de lipoproteina de alta densidad (hdl). | |
NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
MX2011006803A (es) | Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas. | |
MX367309B (es) | Nuevos compuestos antibacterianos. | |
PH12014502623A1 (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
SG10201900541QA (en) | Derivatives of xanthone compounds | |
IN2014DN09314A (es) | ||
MX363480B (es) | Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi. | |
WO2013166282A3 (en) | Methods and compositions for treating bacterial infection | |
MX357352B (es) | Uso de derivados poliaminoisoprenilo en un tratamiento antibiotico o antiseptico. | |
IN2014DN03010A (es) | ||
MX2013002398A (es) | Inhibidores de beta-secretasa (base) para su uso en tratamiento de diabetes. | |
MX337145B (es) | Composiciones farmaceuticas. | |
UA117672C2 (uk) | Антибактеріальні сполуки | |
MY182136A (en) | Pharmaceutical compositions | |
TN2013000012A1 (en) | New aminopyrazoloquinazolines |